NICRodrigo Ortiz 30 September 2025 Job positions opening soon at the CTGCT The CTGCT is going to be officially opening soon applications check what we are looking for. More
ArticlesCliniciansPacientsResearchersGen TherapyResearchCTGCTNICRodrigo Ortiz 25 September 2025 From Film Editing to RNA Editing: How RNA Trans-splicing Could Treat CTNNB1 Syndrome Imagine you're in a movie editing studio, trying to fix a film with some corrupted scenes. The film is vital, as it plays a crucial role in the development and function of an entire ... More
ArticlesCliniciansPacientsClinic studyRegulationCTGCTNICGregor Cuzak 16 July 2025 CTIS public portal – a great tool for finding and exploring clinical trials in Europe The Clinical Trials Information System (CTIS) public portal is a new European tool that allows anyone to access information about clinical trials taking place in the European Union (EU) and European Economic Area (EEA). ... More
ArticlesEventsCliniciansPacientsResearchersGen TherapyRaziskaveCTGCTNICRodrigo Ortiz 8 April 2025 Event Date: 21 March 2025 do: 21 March 2025 • CTGCT’s Role in the GeneH Project: Accelerating Gene Therapy Innovations We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ... More
EventsPacientsBusiness ModelInvestmentCTGCTNICRodrigo Ortiz 13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 • Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry. More
ArticlesPacientsATMPsCell therapyGen TherapyBusiness ModelEconomicsPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 February 2025 How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ... More
ArticlesCliniciansPacientsResearchersATMPsCell therapyResearchCTGCTNICRodrigo Ortiz 25 February 2025 Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ... More
ArticlesPacientsResearchCTGCT 11 February 2025 Women at CTGCT: Voices from the Lab Today we we celebrate the International Day of Women and Girls in Science, we take a moment to spotlight the women working at the Centre for the Technologies of Gene and Cell Therapy (CTGCT) More
ArticlesPacientsResearchersGen TherapyLaboratoryPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 January 2025 The research on combining cytokines with pyroptosis is gaining widespread media coverage Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week". More
LatestMedia ReleasesCliniciansPacientsResearchersResearchCTGCTRodrigo OrtizRodrigo Ortiz 11 December 2024 CTGCT Newsletter, 1st year in review Welcome to the first CTGCT Newsletter featuring a selection of the articles we're most proud of in the last year. More
ArticlesMedia ReleasesResearchersATMPsCell therapyGen TherapyResearchCharite BerlinCTGCTNICTUDUCLUMCUtrechtRodrigo Ortiz 6 December 2024 CTGCT’s Innovation Report on Gene and Cell Therapy We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ) More
ArticlesCliniciansResearchersATMPsCell therapyGen TherapyGLPGMPManufacturing ProcessPre ClinicalRegulationUCLRodrigo Ortiz 4 November 2024 Transforming Advanced Therapy Manufacturing: The Braintree Innovation Centre case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise ... More
